US Patent Issued to Genentech on Aug. 18 for "CDK inhibitors" (Chinese, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,623, issued on Aug. 18, was assigned to Genentech Inc. (South San Francisco, Calif.).

"CDK inhibitors" was invented by Zhilong Hu (Shanghai), Hu He (Shanghai), Fei Zhang (Shanghai), Xiaotian Zhu (Newton, Mass.) and Wenge Zhong (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to multicyclic heteroatom-containing compounds which have CDK inhibitory activity, methods of making the same, and uses thereof. The compounds have the general structural formula (I):The compounds can be used for treating a type of cancer, for example by inhibiting a cyclin-dependent kinase (CDK), such as CDK2, CDK4, and/or CDK6. The d...